Juvederm Voluma 2x1ml
Before 220,00 € · You save 12,00 €
VAT is calculated at checkout according to destination
Volume discount per product · applied automatically in the cart
| Quantity | Price / unit | Discount | You save |
|---|---|---|---|
| 1 unit | 208,00 € | — | — |
| 3+ units | 201,76 € | −3 % | 18,72 € |
| 5+ units Most chosen | 197,60 € | −5 % | 52,00 € |
| 10+ units | 193,44 € | −7 % | 145,60 € |
Fair price, the same for everyone. Every clinic and professional pays the same rate and gets the same volume discounts. Order from 1 unit, no minimum.
Regulated medical device (MDR 2017/745) · sold only to licensed healthcare professionals
Key data
Professional use only- Manufacturer
- Allergan
- Category
- Dermal filler
- Presentation
- 2 × 1 ml
- Price per unit
- 104,00 € excl. VAT
- Reference
- JUV009
- Traceability
- Batch and expiry on the delivery note
- Shipping
- Own logistics centre, Madrid · 2–3 working days
Juvéderm® VOLUMA® with lidocaine is Allergan Aesthetics' benchmark filler for volumetric restoration of the midface. Its cross-linked hyaluronic acid gel with VYCROSS™ technology combines high projection capacity with predictable tissue integration and a documented duration of up to 24 months in a clinical study.
- HA 20 mg/ml
- Lidocaine 3 mg/ml (0.3%)
- Content 2 syringes × 1.0 ml
- Needles 4 × 27G ½"
- Duration up to 24 months
Composition and technology
- Cross-linked hyaluronic acid: 20 mg/ml, BDDE cross-linking agent.
- Lidocaine hydrochloride monohydrate: 3 mg/ml, to reduce discomfort during injection.
- Phosphate buffer pH 7.2 q.s. to 1 ml.
- VYCROSS™ technology: combination of low- and high-molecular-weight hyaluronic acid. Greater cross-linking efficiency allows a lower total HA concentration while maintaining durability, with a homogeneous-texture gel and lower water uptake, resulting in reduced post-treatment swelling.
- Rheological profile: approximate G' of 260–380 Pa depending on the methodology (independent literature data; Allergan does not publish official rheological values). High projection capacity with relatively low cohesivity.
Indications and treatment areas
Injectable implant indicated for facial volume restoration in patients aged 18 and over.
- Cheekbones and malar region
- Zygomatic region and midface projection
- Chin and facial contour definition
Must not be injected into the periorbital region (eyelid, tear trough, crow's feet), glabella, or lips.
Manufacturer's dose limits: maximum 2 ml per treatment area and session; maximum 20 ml of Allergan fillers per 60 kg of body weight per year.
Injection technique and application protocol
- Injection plane: deep dermis, subcutaneous tissue, or supraperiosteal plane, depending on the treated area.
- Included needles: 4 × 27G ½", sterilized by irradiation.
- Aspiration and retrograde injection in accordance with the usual clinical protocol to minimize vascular risk.
- Never inject intravascularly. Do not use in areas with permanent implants.
- Do not combine in the same session with laser treatment, deep peeling, or dermabrasion.
- Documented duration: 96% of responders at 8 weeks and 81.7% at 78 weeks (Callan P. et al., Clin Cosmet Investig Dermatol 2013;6:81–9). Pivotal FDA study: 67.1% of responders at 24 months.
Technical data
| Manufacturer | Allergan Aesthetics / AbbVie — Annecy, France |
|---|---|
| Active ingredient | Cross-linked hyaluronic acid 20 mg/ml |
| Anesthetic | Lidocaine HCl 3 mg/ml (0.3%) |
| Cross-linking agent | BDDE |
| Technology | VYCROSS™ |
| pH | 7.2 (phosphate buffer) |
| Presentation | 2 pre-filled syringes of 1.0 ml |
| Needles | 4 × 27G ½" |
| Sterilization | Moist heat (syringe) / irradiation (needles) |
| Classification | Class III medical device with CE marking (MDR 2017/745) |
| Use | For use exclusively by qualified healthcare professionals |
Storage and package contents
- Storage: between 2 °C and 25 °C, protected from direct sunlight.
- Do not use after the expiry date indicated on the packaging.
- Single-use product. Do not reuse or resterilize.
- Package includes: 2 pre-filled 1.0 ml syringes, 4 27G ½" needles, instructions for use, and traceability labels for the patient record.
Contraindications and warnings
Contraindications: pregnancy and breastfeeding; uncontrolled epilepsy; tendency to hypertrophic or keloid scarring; known allergy to hyaluronic acid or gram-positive bacterial proteins; allergy to lidocaine or amide-type local anesthetics; porphyria; active skin inflammation or infection in the area (acne, herpes); minors.
Precautions and individual assessment: autoimmune disease or immunosuppression; history of rheumatic fever or streptococcal infection; heart disease; severe or multiple allergies (previous anaphylaxis contraindicates treatment); anticoagulant or antiplatelet therapy; treatment with cimetidine or beta-blockers because of the lidocaine.
Always consult the instructions for use included in the packaging before application.
Medical device intended exclusively for qualified healthcare professionals. Technical information based on the manufacturer's official documentation (Juvéderm VOLUMA instructions for use, Allergan Aesthetics/AbbVie) and peer-reviewed scientific literature. This data sheet does not replace the instructions for use supplied with the product.
-
Curated portfolio
-
Controlled storage
-
Full traceability
-
Protected shipping
-
Professionals only
Notified to the health authority · 07-1409-00167.4/2024 · Comunidad de MadridHow we work